Utah Medical Products Return on Tangible Equity 2010-2025 | UTMD

Current and historical return on tangible equity values for Utah Medical Products (UTMD) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Utah Medical Products Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-03-31 $0.01B $0.10B 12.50%
2024-12-31 $0.01B $0.10B 13.18%
2024-09-30 $0.02B $0.11B 13.82%
2024-06-30 $0.02B $0.11B 13.89%
2024-03-31 $0.02B $0.11B 15.02%
2023-12-31 $0.02B $0.11B 15.53%
2023-09-30 $0.02B $0.11B 17.30%
2023-06-30 $0.02B $0.10B 18.28%
2023-03-31 $0.02B $0.10B 19.32%
2022-12-31 $0.02B $0.09B 20.24%
2022-09-30 $0.02B $0.08B 20.00%
2022-06-30 $0.02B $0.08B 20.45%
2022-03-31 $0.02B $0.08B 19.74%
2021-12-31 $0.01B $0.08B 19.18%
2021-09-30 $0.01B $0.08B 18.44%
2021-06-30 $0.01B $0.07B 18.11%
2021-03-31 $0.01B $0.07B 16.06%
2020-12-31 $0.01B $0.07B 17.09%
2020-09-30 $0.01B $0.06B 19.47%
2020-06-30 $0.01B $0.06B 22.12%
2020-03-31 $0.02B $0.05B 28.85%
2019-12-31 $0.02B $0.06B 30.30%
2019-09-30 $0.01B $0.05B 27.86%
2019-06-30 $0.02B $0.05B 32.54%
2019-03-31 $0.02B $0.04B 31.63%
2018-12-31 $0.02B $0.06B 32.43%
2018-09-30 $0.01B $0.06B 23.08%
2018-06-30 $0.01B $0.05B 18.18%
2018-03-31 $0.01B $0.05B 18.95%
2017-12-31 $0.01B $0.05B 19.89%
2017-09-30 $0.02B $0.05B 34.88%
2017-06-30 $0.01B $0.05B 34.57%
2017-03-31 $0.01B $0.04B 33.99%
2016-12-31 $0.01B $0.04B 32.88%
2016-09-30 $0.01B $0.04B 34.29%
2016-06-30 $0.01B $0.04B 37.21%
2016-03-31 $0.01B $0.03B 40.34%
2015-12-31 $0.01B $0.03B 44.44%
2015-09-30 $0.01B $0.03B 48.98%
2015-06-30 $0.01B $0.03B 53.93%
2015-03-31 $0.01B $0.02B 60.00%
2014-12-31 $0.01B $0.02B 66.67%
2014-09-30 $0.01B $0.02B 76.19%
2014-06-30 $0.01B $0.02B 90.57%
2014-03-31 $0.01B $0.02B 111.63%
2013-12-31 $0.01B $0.01B 150.00%
2013-09-30 $0.01B $0.01B 209.52%
2013-06-30 $0.01B $0.01B 440.00%
2013-03-31 $0.01B $0.00B -4000.00%
2012-12-31 $0.01B $0.00B -333.33%
2012-09-30 $0.01B $0.00B -173.91%
2012-06-30 $0.01B $0.00B -109.09%
2012-03-31 $0.01B $-0.01B -83.72%
2011-12-31 $0.01B $-0.01B -53.85%
2011-09-30 $0.01B $-0.01B -233.33%
2011-06-30 $0.01B $-0.01B 87.50%
2011-03-31 $0.01B $-0.02B 30.77%
2010-12-31 $0.01B $0.03B 22.40%
2010-09-30 $0.01B $0.03B 22.22%
2010-06-30 $0.01B $0.03B 22.58%
2010-03-31 $0.01B $0.03B 26.45%
2009-12-31 $0.01B $0.03B 27.12%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.188B $0.041B
Utah Medical Products is in the business of producing cost-effective devices for the healthcare industry which are predominantly proprietary, disposable and for hospital use. The company's success in rapidly producing solutions comes from its proven ability to integrate a number of engineering and technical disciplines in electronics, software, mechanical packaging, instrumentation, optics and materials. The resulting proprietary products represent significant incremental improvementsover existing clinical techniques.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $233.799B 28.11
Boston Scientific (BSX) United States $157.605B 39.46
Stryker (SYK) United States $150.214B 31.41
EssilorLuxottica (ESLOY) France $126.765B 0.00
Medtronic (MDT) Ireland $110.324B 15.64
Lonza Group Ag (LZAGY) Switzerland $50.804B 0.00
Haleon (HLN) United Kingdom $46.676B 26.62
ResMed (RMD) United States $37.413B 28.10
GE HealthCare Technologies (GEHC) United States $34.057B 16.17
Agilent Technologies (A) United States $33.852B 22.07
Terumo (TRUMY) Japan $27.835B 36.15
Koninklijke Philips (PHG) Netherlands $23.245B 16.31
Insulet (PODD) United States $22.033B 86.49
Zimmer Biomet Holdings (ZBH) United States $18.095B 11.62
Baxter (BAX) United States $15.595B 11.64
Smith & Nephew SNATS (SNN) United Kingdom $13.236B 0.00
Demant (WILYY) Denmark $9.110B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.639B 23.10
Lantheus Holdings (LNTH) United States $5.638B 14.22
Prestige Consumer Healthcare (PBH) United States $3.998B 17.86
Perrigo (PRGO) Ireland $3.649B 9.25
Haemonetics (HAE) United States $3.545B 16.15
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.334B 27.70
ICU Medical (ICUI) United States $3.244B 23.92
QuidelOrtho (QDEL) United States $1.952B 13.43
LeMaitre Vascular (LMAT) United States $1.866B 41.70
AtriCure (ATRC) United States $1.598B 0.00
AdaptHealth (AHCO) United States $1.289B 13.08
Acuren (TIC) United States $1.271B 0.00
Green Thumb Industries (GTBIF) United States $1.111B 25.00
Phibro Animal Health (PAHC) United States $1.040B 13.30
Neogen (NEOG) United States $1.027B 13.14
BioLife Solutions (BLFS) United States $1.021B 0.00
Kestra Medical Technologies (KMTS) United States $0.907B 0.00
InMode (INMD) Israel $0.897B 9.04
Owens & Minor (OMI) United States $0.685B 5.69
CeriBell (CBLL) United States $0.683B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.629B 0.00
Evolus (EOLS) United States $0.589B 0.00
Curaleaf Holdings (CURLF) Canada $0.531B 0.00
Capricor Therapeutics (CAPR) United States $0.509B 0.00
Valneva SE (VALN) France $0.494B 0.00
Surmodics (SRDX) United States $0.412B 0.00
Tilray Brands (TLRY) Canada $0.403B 0.00
VAREX IMAGING (VREX) United States $0.354B 13.00
Quanterix (QTRX) United States $0.332B 0.00
SNDL (SNDL) Canada $0.323B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.301B 0.00
Viemed Healthcare (VMD) United States $0.274B 23.07
Cerus (CERS) United States $0.271B 0.00
ZimVie (ZIMV) United States $0.258B 11.72
Sanuwave Health (SNWV) United States $0.256B 0.00
Sanara MedTech (SMTI) United States $0.253B 0.00
Brainsway (BWAY) Israel $0.250B 66.10
Cresco Labs (CRLBF) United States $0.246B 0.00
Aurora Cannabis (ACB) Canada $0.233B 69.17
Biote (BTMD) United States $0.230B 6.46
OraSure Technologies (OSUR) United States $0.225B 0.00
Canopy Growth (CGC) Canada $0.224B 0.00
TriSalus Life Sciences (TLSI) United States $0.201B 0.00
Omeros (OMER) United States $0.188B 0.00
High Tide (HITI) Canada $0.184B 0.00
Organigram Global (OGI) Canada $0.181B 0.00
Verano Holdings (VRNOF) United States $0.177B 0.00
Exagen (XGN) United States $0.149B 0.00
Vireo Growth (VREOF) United States $0.144B 0.00
FitLife Brands (FTLF) United States $0.120B 14.81
Jin Medical (ZJYL) China $0.102B 0.00
Fonar (FONR) United States $0.092B 11.90
Oramed Pharmaceuticals (ORMP) United States $0.088B 0.00
Veru (VERU) United States $0.085B 0.00
Apyx Medical (APYX) United States $0.082B 0.00
Quipt Home Medical (QIPT) United States $0.078B 0.00
Zynex (ZYXI) United States $0.077B 0.00
Cytosorbents (CTSO) United States $0.077B 0.00
TerrAscend (TSNDF) Canada $0.077B 0.00
MacroGenics (MGNX) United States $0.075B 0.00
InterCure (INCR) Israel $0.068B 0.00
Agape ATP (ATPC) $0.066B 0.00
ImmuCell (ICCC) United States $0.061B 0.00
Jushi Holdings (JUSHF) United States $0.057B 0.00
Nephros (NEPH) United States $0.041B 55.14
United-Guardian (UG) United States $0.037B 12.94
Modular Medical (MODD) United States $0.037B 0.00
Rockwell Medical (RMTI) United States $0.027B 0.00
Safety Shot (SHOT) United States $0.023B 0.00
Allurion Technologies (ALUR) United States $0.018B 0.00
INLIF (INLF) $0.016B 0.00
Meihua Medical Technologies (MHUA) China $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.014B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Senestech (SNES) United States $0.010B 0.00
Innovative Eyewear (LUCY) United States $0.006B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00